Fagron daughter suspected of fraud

A US subsidiary of Dutch-Belgian pharmacy Fagron is being investigated in the US for fraud.

The FBI suspects that subsidiary Freedom Pharmaceuticals benefited from malpractice in filing claims with insurance companies, report the FD. That newspaper has documents where it appears from.

Freedom benefited from the activities of MedHealth RX, a company that reimbursement rules for breaking certain medications. MedHealth RX was founded by the former director of Fagron North America.
  
    
     
      
        0:35
      
     Bikini Babe breaks out police car
     
     
      
        0:32
      
     Painful: rejection on live TV
     
     
      
        3:30
      
     Princess Charlene in power Fr.